Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Blanket Purchase Agreement V797P5967X-VA25517A0007
Award Date
7/1/17
Last Date to Order
5/31/19
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
42
Activity
5
Contract IDVs
Contract Awards
2
Transactions
5
Price Lists
Opportunity Stack
Federal Agency
Veterans Integrated Service Network 15
Awardee
Cepheid
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Invitro Diagnostics, Reagents, Test
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Invitro Diagnostics, Reagents, Test (FSS-65-VII)
Master GSA Schedule
V797P5967X
Federal Supply Schedule
V797P5967X-VA25517A0007
Blanket Purchase Agreement
2
Federal Contract Awards
Description
Update #1
MRSA AND C. DIFF KITS
Posted 3/7/17, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00004
MRSA AND C. DIFF KITS
Exercise an Option
$0
6/1/18
P00003
MRSA AND C. DIFF KITS
Other Administrative Action
$0
7/26/17
P00002
MRSA AND C. DIFF KITS
Other Administrative Action
$0
7/7/17
P00001
MRSA AND C. DIFF KITS
Other Administrative Action
$0
6/19/17
Not listed
MRSA AND C. DIFF KITS
Not listed
$0
3/7/17
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
BPA Call VA25517A0007-36C25518N3035
This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the provision of MRSA and C. diff test kits and reagents. The award, valued at $883,413.29, was made by the Department of Veterans Affairs (VA) Veterans Health Administration under a Blanket Purchase Agreement (BPA) call against a General Services Administration (GSA) Schedule contract for In Vitro Diagnostics, Reagents, and Tests. The contract has a firm-fixed price pricing type and a period of performance through April 30, 2020. As the prime contractor, Cepheid, a subsidiary of the Danaher Corporation, supplies diagnostic testing products and services to support the clinical programs of various federal agencies, including the VA, the Defense Logistics Agency, and the Indian Health Service. Cepheid also holds separate contracts and subcontracts related to infectious disease research and COVID-19 testing.
Cepheid
$883.4k
7/1/18
4/30/20
9/10/20
BPA Call VA25517A0007-VA25517J2639
This is a firm-fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $5,994,214.67, is for the provision of MRSA and C. diff test kits and is funded through the VA's Invitro Diagnostics, Reagents, Test (FSS-65-VII) federal supply schedule. As the original equipment manufacturer, Cepheid will deliver reagents, test kits, instruments, and testing platforms to support the VA's clinical diagnostic programs. Cepheid is a subsidiary of the Danaher Corporation and has also received awards from other federal agencies, including the Defense Logistics Agency and the Department of Health and Human Services, to supply infectious disease testing products and services. This contract does not utilize a set-aside designation.
Cepheid
$6.0m
7/1/17
4/30/19
4/11/19